Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 October 2022 | Story Tsholo Maleho
UFS librarian Nambitha Manqola
UFS librarian Nambitha Manqola received top honours at the 2022 Library and Information Association of South Africa conference, scooping the association’s Emerging Librarian Award.

The University of the Free State Library and Information Services (UFS LIS) continues to deliver world-class services, with its staff members receiving national accolades.

Highlighting the library’s positive contributions, Nambitha Manqola, Chief Officer in the UFS LIS on the Bloemfontein Campus, recently scooped the Library and Information Association of South Africa (LIASA) - Nevada LMS Emerging Librarian Award at the association’s national conference hosted in Gauteng from 4 to 7 October 2022.

 

A role model for the Library and Information Services community

This award is given to someone who demonstrates characteristics indicating that they are a role model for the library and information services community, someone whose contributions could have a long-term impact on the sector, and someone who will be an ambassador for LIASA, Nevada LMS, and librarianship in the coming years, including embracing the post-modern digital landscape.

This accolade recognises the achievements and accomplishments of emerging, inspiring, and exceptional public, academic, school, and special librarians who have earned their LIS qualification within the past five years.

Manqola is known throughout the UFS LIS and Free State library community as a well-rounded individual who is gifted and skilled in a variety of areas, particularly technology. She is based in the UFS LIS Digital Scholarship Centre and is responsible for research data management, and library systems.

Her contribution to the UFS library's growth and marketing, especially during the COVID-19 pandemic, has left a lasting impression, making her an ambassador for how library professionals should embrace change and technology.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept